Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report

BACKGROUND: Teriflunomide, the active metabolite of leflunomide, is a disease-modifying therapy drug used for the treatment of multiple sclerosis (MS), yet the complications associated with this drug remain not fully understood. Here we present the rare case of a 28-year-old female MS patient who de...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ke, Zhang, Mengjie, Yang, Shilin, Yu, Gang, Zheng, Peng, Qin, Xinyue, Feng, Jinzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131458/
https://www.ncbi.nlm.nih.gov/pubmed/37101279
http://dx.doi.org/10.1186/s12883-023-03146-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131458/
https://www.ncbi.nlm.nih.gov/pubmed/37101279
http://dx.doi.org/10.1186/s12883-023-03146-1

Ejemplares similares